Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Dermatology and Therapy
Published in: Dermatology and Therapy 4/2021

Open Access 01-08-2021 | Shingles | Correction

Correction to: Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review

Authors: Javier Diez-Domingo, Raunak Parikh, Amit B. Bhavsar, Elisa Cisneros, Natalia McCormick, Nicolas Lecrenier

Published in: Dermatology and Therapy | Issue 4/2021

Login to get access

Excerpt

Authors would like to correct the errors in their publication.
1.
On the Results and Discussion section, Description of HZ cases in patients with COVID-19, subsection Demographic and Co-Morbid conditions:
There were cases with known risk factors for HZ, which included age over 50 years of age ( n=18 ),
The correct number is 19.
 
…
Metadata
Title
Correction to: Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review
Authors
Javier Diez-Domingo
Raunak Parikh
Amit B. Bhavsar
Elisa Cisneros
Natalia McCormick
Nicolas Lecrenier
Publication date
01-08-2021
Publisher
Springer Healthcare
Keywords
Shingles
COVID-19
Published in
Dermatology and Therapy / Issue 4/2021
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-021-00563-3

Other articles of this Issue 4/2021

Dermatology and Therapy 4/2021 Go to the issue

Brief Report

Confidence in Biosimilar Drugs is Not Much Improved by Framing Them as the “Gold” Alternative Treatment Option to Bio-originators

Review

Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience

Brief Report

Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis

Original Research

Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials

Original Research

Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study

Original Research

Absorbable Barbed Threads for Lower Facial Soft-Tissue Repositioning in Asians
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits